Takeda Pharmaceutical Ltd ADR (TAK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,569,450 | N/A | N/A | N/A | 3,206,470 |
| Depreciation Amortization | 2,433,380 | N/A | N/A | N/A | 1,625,180 |
| Other Working Capital | 149,180 | N/A | N/A | N/A | 822,000 |
| Other Operating Activity | -428,740 | 0 | 0 | 0 | -1,379,220 |
| Operating Cash Flow | $3,723,270 | $N/A | $N/A | $N/A | $4,274,430 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -848,520 | N/A | N/A | N/A | -518,740 |
| Net Acquisitions | -977,880 | N/A | N/A | N/A | 0 |
| Other Investing Activity | 478,760 | 0 | 0 | 0 | -13,374,600 |
| Investing Cash Flow | $-1,347,640 | $N/A | $N/A | $N/A | $-13,893,340 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -1,719,620 | N/A | N/A | N/A | -1,803,560 |
| Other Financing Activity | -102,140 | 0 | 0 | 0 | 6,804,680 |
| Financing Cash Flow | $-1,821,760 | $N/A | $N/A | $N/A | $5,001,120 |
| Exchange Rate Effect | 551,250 | N/A | N/A | N/A | -696,700 |
| Beginning Cash Position | 5,496,380 | N/A | N/A | N/A | 11,083,410 |
| End Cash Position | 6,601,510 | N/A | N/A | N/A | 5,768,930 |
| Net Cash Flow | $1,105,120 | $N/A | $N/A | $N/A | $-5,314,480 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,723,270 | N/A | N/A | N/A | 4,274,430 |
| Free Cash Flow | 3,723,270 | 0 | 0 | 0 | 4,274,430 |